Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis — Stella
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(18 sites)
Brazil
Hospital Nossa Senhora da Conceicao CRS (Site ID: 12201), Porto Alegre
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS (Site ID: 12101), Rio de Janeiro
India
Byramjee Jeejeebhoy Government Medical College (BJMC) CRS (Site ID: 31441), Pune
Kenya
Moi University Clinical Research Center (MUCRC) CRS (Site ID: 12601), Eldoret
Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS (Site ID: 12501), Kericho
Malawi
Malawi CRS (Site ID: 12001), Lilongwe
Mexico
Nutrición-Mexico CRS (Site ID: 32078), Mexico City
Peru
Socios en Salud Sucursal Peru CRS (Site ID: 31985), Lima
Barranco CRS (Site ID:11301), Lima
Philippines
TB HIV Innovations and Clinical Research Foundation Corp (Site ID: 31981), Cavite
South Africa
Durban International CRS (Site ID:11201), Durban
University of the Witwatersrand Helen Joseph (WITS HJH) CRS (Site ID: 11101), Johannesburg
Tanzania
Kilimanjaro Christian Medical Centre (KCMC) (Site ID: 5118), Moshi